For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Careers
Contact Us
日本語
Menu
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Careers
Contact Us
日本語
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Careers
Contact Us
日本語
Menu
For Institutions
For Individuals
The Science
What are iPSCs?
iPSC FAQ
Latest in Regenerative Medicine
FAQ
News
About Us
Our Vision
Company Overview
Careers
Contact Us
日本語
Twitter
Facebook-f
News
All
Press
Media
Events
Other
[Summary of Research]Kyoto University has generated iPS cells with less risk of rejection by genome editing
•
March 2, 2021
•
Other
I Peace CEO Tanabe pressents at RINK FESTIVAL 2021
•
February 25, 2021
•
Events
[Summary of Research]Kyoto University has succeeded in regenerating T-cells from human iPS cells that enhance effects of cancer immunotherapy(2018)
•
February 22, 2021
•
Other
[Summary of research available] Kyoto University developed a scalable method to regenerate T-cells from iPSCs
•
February 5, 2021
•
Other
Renewal of I Peace website
•
February 5, 2021
•
Other
I Peace in the News – the NIKKAN KOGYO SHIMBUN December 28, 2020
•
January 10, 2021
•
Media
I Peace, Inc. and Avery Therapeutics announce collaboration to bring iPSC derived cell therapy for heart failure to the clinic
•
December 29, 2020
•
Press
I Peace, Inc. obtains IRB Approval for Production of Clinical and Research-Grade iPSCs for Commercial Use
•
December 4, 2020
•
Press
I Peace CEO Koji Tanabe to Present at 2020 Virtual Cell & Gene Meeting on the Mesa
•
October 7, 2020
•
Events
I Peace CEO Koji Tanabe participates as a speaker in the the International Industrial Fair 2020 Kobe
•
September 5, 2020
•
Events
Reach out to us to learn more
Contact Us
